GAUDIO, AGOSTINO
 Distribuzione geografica
Continente #
EU - Europa 3.196
NA - Nord America 2.226
AS - Asia 1.463
SA - Sud America 430
AF - Africa 46
OC - Oceania 6
Totale 7.367
Nazione #
US - Stati Uniti d'America 2.174
RU - Federazione Russa 1.760
SG - Singapore 605
CN - Cina 453
BR - Brasile 358
IE - Irlanda 318
SE - Svezia 307
DE - Germania 262
HK - Hong Kong 169
IT - Italia 134
FI - Finlandia 108
FR - Francia 99
VN - Vietnam 90
UA - Ucraina 63
GB - Regno Unito 59
IN - India 49
PL - Polonia 24
CA - Canada 23
AR - Argentina 20
TR - Turchia 16
VE - Venezuela 16
BE - Belgio 15
MX - Messico 15
BD - Bangladesh 14
ES - Italia 14
ZA - Sudafrica 14
IQ - Iraq 13
AT - Austria 8
CO - Colombia 8
JP - Giappone 8
MA - Marocco 8
NL - Olanda 7
PK - Pakistan 7
AU - Australia 6
CL - Cile 6
CZ - Repubblica Ceca 6
PY - Paraguay 6
CI - Costa d'Avorio 5
EC - Ecuador 5
PE - Perù 5
HN - Honduras 4
KE - Kenya 4
LT - Lituania 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
GE - Georgia 3
ID - Indonesia 3
IR - Iran 3
KG - Kirghizistan 3
KR - Corea 3
OM - Oman 3
UY - Uruguay 3
GT - Guatemala 2
JM - Giamaica 2
JO - Giordania 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 7.367
Città #
Moscow 470
Ashburn 363
Dublin 318
Singapore 315
Chandler 238
Dallas 236
Nyköping 171
Beijing 149
Munich 147
Jacksonville 146
Hong Kong 143
San Jose 125
The Dalles 81
New York 73
Helsinki 61
Los Angeles 52
Lauterbourg 50
Princeton 46
Messina 45
Medford 43
Ann Arbor 37
Ho Chi Minh City 35
Dearborn 34
São Paulo 33
Des Moines 31
Cambridge 30
Boardman 29
Bremen 29
Buffalo 23
Shenyang 22
Tianjin 21
Frankfurt am Main 19
Guangzhou 19
Warsaw 19
Hanoi 18
Brussels 15
Houston 15
Jinan 15
Nanjing 15
Turku 15
Orem 14
Redondo Beach 14
Santa Clara 13
Belo Horizonte 12
Pune 12
Seattle 12
Wilmington 12
Düsseldorf 11
Johannesburg 11
Catania 10
Chennai 10
San Mateo 9
Boston 8
Hebei 8
Lancaster 8
Manchester 8
Montreal 8
Mumbai 8
Brooklyn 7
Central 7
Nuremberg 7
Poplar 7
Sheung Shui 7
Strasbourg 7
Tokyo 7
Ankara 6
Denver 6
Falls Church 6
Hangzhou 6
Mexico City 6
Shanghai 6
Taiyuan 6
Woodbridge 6
Zhengzhou 6
Abidjan 5
Brno 5
Fuzhou 5
Haikou 5
Porto Alegre 5
Rio de Janeiro 5
Santiago 5
Shenzhen 5
Baghdad 4
Bauru 4
Brasília 4
Chicago 4
Council Bluffs 4
Da Nang 4
Goiânia 4
Lahore 4
Lappeenranta 4
Lima 4
London 4
Melbourne 4
Nairobi 4
Nanchang 4
Portsmouth 4
Recife 4
San Francisco 4
Sorocaba 4
Totale 4.149
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 290
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 220
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 214
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 214
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 187
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 187
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 181
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 179
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 178
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 175
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 173
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 173
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 170
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 169
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 167
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 161
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 160
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 152
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 152
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 149
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 144
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 142
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 141
CORRELATION BETWEEN FAMILY HISTORY OF HYPERTENSION AND HAEMOSTATIC DISORDERS 140
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 140
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 140
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 138
Early vascular ageing biomarkers in osteoporotic outpatients: a pilot study 136
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 135
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 135
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 131
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 129
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 128
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 122
Renal function is associated with changes in bone mineral density in postmenopausal osteoporotic women treated with Denosumab: data from a retrospective cohort study 122
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania 122
Clinical and molecular description of the first Italian cohort of 33 subjects with hypophosphatasia 120
Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D 120
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 115
VITAMIN D PROMOTES BONE MINERAL DENSITY ACCRUAL AFTER DISCONTINUATION OF ALENDRONATE 109
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 103
Familiar osteopoikilosis: Case report with differential diagnosis and review of the literature 103
Pharmacological management of severe postmenopausal osteoporosis 101
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 98
Pathogenesis of Thalassemia Major-Associated Osteoporosis: Review of the Literature and Our Experience 98
Menopause modulates homocysteine levels in diabetic and non-diabetic women. 95
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 84
Calf circumference predicts changes of bone mineral density in postmenopausal osteoporotic women receiving denosumab 81
POS1119 A SINGLE DOSE OF ZOLEDRONATE INDUCES MODIFICATIONS OF SERUM VEGF IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN 79
Quantitative ultrasound and DXA measurements in aromatase inhibitor-treated breast cancer women receiving denosumab 75
IMPACT OF ANXIETY LEVELS ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN TREATED WITH ORAL BIPHOSPHONATES: RESULTS FROM A LONGITUDINAL COHORT STUDY 73
Exploring the Association Between Platelet Count, the Systemic Immune Inflammation Index, and Fracture Risk in Postmenopausal Women with Osteoporosis: A Cross-Sectional Study 71
Pain in Osteoporosis: Current and Future Strategies 65
Osteoporosis and Fragility Fractures in Type 2 Diabetes 30
null 21
null 21
Totale 7.458
Categoria #
all - tutte 23.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 17 19 7
2021/2022414 1 63 14 7 14 6 48 12 32 76 36 105
2022/2023945 62 110 51 53 79 94 10 63 376 12 21 14
2023/2024299 20 39 15 28 14 81 4 39 0 11 14 34
2024/20251.305 29 21 17 83 56 81 75 219 314 91 119 200
2025/20263.830 212 261 244 243 333 816 457 572 567 125 0 0
Totale 7.458